High-performance bio-absorbable polymers, absorbable hemostatic suturing tools, and advanced surgical dressings manufactured under strict ISO 13485:2016 standards for immediate delivery to the Israeli market.
Precision braided synthetic absorbable suture with accelerated breakdown matrix. Excellent knot security for trauma and delicate tissue ligation.
Get a Quote
EO sterilized 75cm synthetic suture configured for rapid tensile maintenance. Ideal for surgical procedures requiring tissue approximation.
Get a Quote
Waterproof, breathable matrix providing exudate control and hemostatic compression for surgical sites, burns, and trauma wound care.
Get a Quote
USP sizes 3-0 and 4-0 precision-swaged needles offering exceptional handling, low tissue drag, and reliable absorption profile.
Get a Quote
Comprehensive hospital surgical suture threads tailored for high-volume surgical centers and emergency field kits in Israel.
Get a Quote
Reinforced polymer structure designed for high-stress tissue closing, fascia repair, and veterinary surgical applications.
Get a Quote
Cost-effective, hospital-grade PGA suture lines meeting global pharmacopeia standards for general surgery and trauma care.
Get a Quote
Single-use sterile surgical suture packs optimized for quick deployment in field medicine, trauma suites, and outpatient clinics.
Get a QuoteSurgical bleed management in modern operative environments demands immediate, reliable intraoperative hemostasis. As a premier global manufacturer and dedicated hemostatic powder factory & exporter to the Israel market, we deliver advanced biomaterial solutions engineered to achieve rapid hemostasis across complex anatomical sites where traditional ligatures, electrocautery, or sutures are impractical or contraindicated.
Our proprietary absorbable hemostatic powder utilizes microporous polysaccharide spheres (MPH) synthesized from purified plant starch through a controlled cross-linking polymer process. Upon topical administration to an active bleeding site, the biocompatible hydrophilic powder exhibits a dual-action mechanism:
Underpinned by our state-of-the-art manufacturing facility in Bengaluru, India, our manufacturing ecosystem guarantees complete quality control, single-site traceability, and regulatory compliance for Israeli medical device distributors.
Manufactured under ISO 13485:2016, CE / EU MDR 2017/745 technical files, ISO 9001:2015, and WHO-GMP. Fully compliant with United States Pharmacopeia (USP) and European Pharmacopoeia (EP) monographs.
Extrusion, bio-polymer formulation, filling, packaging, and Ethylene Oxide (EO) sterilization take place in a single facility. Every batch maps directly to raw material lots, pull-test logs, and EO charts.
Custom packaging configurations, sterile pouch printing, multi-language Instructions for Use (IFU) including Hebrew/English documentation, GS1/UDI barcode formatting, and customized applicator lengths.
Israel's healthcare sector, renowned for world-class medical innovation and rigorous clinical protocols, requires versatile hemostatic agents suited for tertiary trauma centers, specialized surgical suites, and emergency field operations.
In high-velocity trauma care and tactical field dressing units (e.g., Magen David Adom and Israel Defense Forces Medical Corps), ready-to-use absorbable hemostatic powder offers rapid intervention for severe arterial oozing, blast injuries, and deep tissue lacerations prior to definitive surgical transport.
During vascular grafting, coronary artery bypass grafting (CABG), and peripheral revascularization, oozing along suture lines or synthetic vascular prostheses can be controlled cleanly without compromising graft patency or causing distal embolization.
Using long, specialized bellows applicators, surgical teams operating in narrow pelvic or abdominal cavities (Urology, Gynecology, General Surgery) can spray fine powder particles across broad diffuse oozing surfaces during prostatectomies or hysterectomies.
Cancelling cancellous bone bleeding and spinal epidural venous plexus oozing where mechanical bone wax is undesirable. The absorbable matrix settles into trabecular bone spaces, promoting biological clot organization.
Navigating the Israeli medical device landscape requires an acute understanding of clinical preferences, market growth drivers, and strict Ministry of Health (AMAR) compliance requirements.
Objective comparative evaluation of absorbable powder matrices versus conventional intraoperative hemostatic modalities.
| Hemostatic Solution | Base Composition | Mechanism of Action | Time to Hemostasis | Absorption Time | Storage Requirement |
|---|---|---|---|---|---|
| Absorbable Hemostatic Powder (MPH) | Cross-linked Plant Starch | Dehydration & Cellular Matrix Concentration | 2 – 4 minutes | 7 – 14 days | Ambient (15°C - 30°C) |
| Oxidized Regenerated Cellulose (ORC) | Carboxylated Cellulose | Low pH Protein Denaturation & Mesh Barrier | 3 – 8 minutes | 14 – 28 days | Ambient (15°C - 30°C) |
| Absorbable Gelatin Sponge | Porcine / Bovine Collagen | Platelet Surface Activation | 5 – 10 minutes | 4 – 6 weeks | Ambient (15°C - 30°C) |
| Thrombin / Fibrin Sealant | Human/Bovine Plasma Thrombin | Direct Fibrin Clot Synthesis | 1 – 3 minutes | Variable (Weeks) | Refrigerated / Frozen (-18°C) |
| Surgical Bone Wax | Beeswax & Isopropyl Palmitate | Passive Mechanical Plug | Immediate (Tamponade) | Non-Absorbable | Ambient (Cool Place) |
Direct, transparent answers regarding regulatory clearance, order logistics, packaging customization, and product specifications for the Israel market.
Expand your surgical distribution portfolio in Israel with high-margin, CE-certified absorbable hemostatic powder, suture matrices, and specialized wound closure products. Connect with our dedicated export director today for pricing, technical dossiers, and evaluation samples.